(Q34593188)

3 August 2017

1 reference

title

Ramoplanin: a topical lipoglycodepsipeptide antibacterial agent (English)

1 reference

3 August 2017

Patricia Fulco

1

1 reference

3 August 2017

Richard P Wenzel

series ordinal

2

1 reference

3 August 2017

publication date

1 December 2006

1 reference

Expert Review of Anti-infective Therapy

3 August 2017

published in

1 reference

3 August 2017

volume

4

1 reference

3 August 2017

issue

6

1 reference

3 August 2017

page(s)

939-945

1 reference

Nosocomial bloodstream infections in United States hospitals: a three-year analysis

3 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Nosocomial bloodstream infections in US hospitals: analysis of 24,179 cases from a prospective nationwide surveillance study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Perspective: Attributable mortality--the promise of better antimicrobial therapy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Ramoplanin: a lipoglycodepsipeptide antibiotic

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Ramoplanin: a novel antimicrobial agent with the potential to prevent vancomycin-resistant enterococcal infection in high-risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Survey of long-term-care facilities in Iowa for policies and practices regarding residents with methicillin-resistant Staphylococcus aureus or vancomycin-resistant enterococci

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Mupirocin-based decolonization of Staphylococcus aureus carriers in residents of 2 long-term care facilities: a randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Clostridium difficile in long-term-care facilities for the elderly

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Community-acquired methicillin-resistant Staphylococcus aureus: current perspectives.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Community-associated methicillin-resistant Staphylococcus aureus: a review

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Staphylococcus aureus Panton-Valentine leukocidin directly targets mitochondria and induces Bax-independent apoptosis of human neutrophils.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Total synthesis of the ramoplanin A2 and ramoplanose aglycon

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Inhibition of peptidoglycan biosynthesis by ramoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Ramoplanin inhibits bacterial transglycosylases by binding as a dimer to lipid II.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

The 1.9 Å crystal structure ofEscherichia coliMurG, a membrane-associated glycosyltransferase involved in peptidoglycan biosynthesis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Total synthesis and structure of the ramoplanin A1 and A3 aglycons: two minor components of the ramoplanin complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

In vitro activity of ramoplanin against Clostridium difficile, including strains with reduced susceptibility to vancomycin or with resistance to metronidazole

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

In vitro activities of ramoplanin, teicoplanin, vancomycin, linezolid, bacitracin, and four other antimicrobials against intestinal anaerobic bacteria

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

Effective suppression of vancomycin-resistant Enterococcus species in asymptomatic gastrointestinal carriers by a novel glycolipodepsipeptide, ramoplanin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

A predominantly clonal multi-institutional outbreak of Clostridium difficile-associated diarrhea with high morbidity and mortality

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

European survey of vancomycin-resistant enterococci in at-risk hospital wards and in vitro susceptibility testing of ramoplanin against these isolates

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14787210.4.6.939

A-16686, a new antibiotic from Actinoplanes. I. Fermentation, isolation and preliminary physico-chemical characteristics

21 January 2018

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.37.309

Ramoplanin (A-16686), a new glycolipodepsipeptide antibiotic. III. Structure elucidation

1 reference

12 April 2024

https://opencitations.net/index/api/v1/citations/10.7164/ANTIBIOTICS.42.254

Identifiers

DOI

10.1586/14787210.4.6.939

1 reference

3 August 2017

1 reference